This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2023
Title: Thomas Rysiok: Innovator in Fusion Protein Technology
Introduction
Thomas Rysiok is a notable inventor based in Dudenhofen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work aims to address critical health issues, such as cartilage disorders.
Latest Patents
Rysiok holds a patent for a fusion protein comprising an FGF-18 moiety. This invention relates to new fusion proteins that combine an FGF-18 moiety with an anti-NGF moiety. The fusion protein has potential applications in treating cartilage disorders, including osteoarthritis and cartilage injuries.
Career Highlights
Throughout his career, Thomas Rysiok has focused on advancing medical treatments through innovative protein engineering. His work has garnered attention for its potential to improve the quality of life for individuals suffering from cartilage-related conditions.
Collaborations
Rysiok has collaborated with notable colleagues, including Christian Brenneis and Stefan Zielonka. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Thomas Rysiok's contributions to fusion protein technology highlight his commitment to advancing medical science. His patent for a fusion protein demonstrates the potential for innovative solutions in treating cartilage disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile